PLx Pharma Inc.
PLx Pharma Inc. (PLXP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PLXP · as of Jun 9, 2026
Key Statistics
Explore PLx Pharma Inc. Data
plxp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 40.0%
Competitors & Peers
plxp competitorsPLXP
APDN
ATNX
AWH
BPTS
EIGRQStock Performance
Full HistoryAbout PLx Pharma Inc.
PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery platform technology, having successfully transitioned into the commercial stage. The company's primary offerings include …
what is plx pharma inc. · plxp stock overview · plx pharma inc. company profile · who is plx pharma inc. ceo · plxp NASDAQ · plx pharma inc. headquarters · plx pharma inc. business segments
About Stock Overview & Key Data
PLx Pharma Inc. (PLXP) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Mar 13, 2014. As of the latest trading session, PLXP stock price is $0.09, with a market capitalization of $2.5M. The stock has returned -95.71% over the past 12 months and -53.72% year-to-date.
According to 5 Wall Street analysts, the consensus rating for PLx Pharma Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2021, PLx Pharma Inc. reported revenue of $8.2M and net income of -$51.5M. For detailed data — including PLx Pharma Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, PLx Pharma Inc. (PLXP) stock price is $0.09. The stock is traded on NASDAQ under the ticker symbol PLXP. The 52-week range is $0.01 – $3.41.